July 30, 2021

New Research Highlights Important Pathway for Drug Treatment in Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementia

Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for their new findings which could change the trajectory of treatment for key neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and ALS. Currently, these diseases together affected over 6.5 million Americans, making this finding of incredible significance.